INV.NASDAQInnventure, INC

8-K: Innventure Closes $40M Public Offering, Boosts Accelsius Stake

Sentiment:

Capital Raise Announcement


Innventure, Inc. announced the closing of a $40 million registered direct offering of common stock to four institutional investors, aiming to repay convertible debentures and fund working capital.

Capital raiseInnventure, Inc. completed a registered direct offering of 11,428,572 shares of common stock.The offering generated gross proceeds of approximately $40 million.The shares were sold to four institutional investors at a per share purchase price of $3.50.Titan Partners Group LLC acted as the sole placement agent, receiving a 7.0% cash fee and up to $100,000 in expense reimbursement.

Summary

  • Innventure, Inc. (NASDAQ: INV) has closed a registered direct offering of 11,428,572 shares of its common stock to four institutional investors.
  • The offering generated gross proceeds of approximately $40 million, before deducting placement agent fees and other offering expenses.
  • Net proceeds are intended for the full repayment of outstanding convertible debentures, as well as for working capital and general corporate purposes.
  • The company may use a portion of the proceeds to exercise its right to receive equity in Accelsius, a subsidiary, in lieu of cash for Accelsius' repayment of approximately $8 million in intercompany convertible debt and interest.
  • If exercised, the Accelsius debt would convert into the same series of securities purchased by strategic investors in Accelsius' recently announced $65 million Series B-1 Units sale, which was based on a post-money valuation of approximately $665 million.
  • Titan Partners Group LLC served as the sole placement agent for the offering, receiving a cash fee equal to 7.0% of the aggregate proceeds and reimbursement for out-of-pocket expenses up to $100,000.
  • Executive officers and directors of Innventure have entered into 30-day lock-up agreements restricting sales of common stock and common stock equivalents following the closing of the offering.
  • Innventure has also agreed to certain restrictions on the issuance and sale of common stock or common stock equivalents for a 30-day period post-closing.

Sentiment

Score: 7

Explanation: The successful completion of a $40 million capital raise, coupled with the strategic intent to repay debt and invest in a high-growth subsidiary (Accelsius) with a significant market opportunity, indicates a positive financial and strategic move for the company. The dilution from the share issuance is a common aspect of equity raises and is offset by the strengthened balance sheet and growth prospects.

Positives

  • Successfully raised approximately $40 million in gross proceeds, strengthening the company's capital position.
  • The proceeds are expected to fully repay all outstanding convertible debentures, which will improve the balance sheet and reduce financial leverage.
  • The offering provides enhanced flexibility to increase ownership in Accelsius, a subsidiary with a rapidly scaling business in the 2-phase, direct-to-chip cooling market.
  • Accelsius boasts an expected sales opportunity pipeline exceeding $1 billion and significant strategic engagement across its industry, indicating strong growth potential.
  • The capital infusion accelerates Innventure's long-term strategy of commercializing breakthrough technology solutions and building companies with billion-dollar valuations.

Negatives

  • The issuance of 11,428,572 new shares of common stock will result in dilution for existing shareholders.
  • Placement agent fees of 7.0% of gross proceeds and up to $100,000 in expenses reduce the net proceeds available to the company.

Risks

  • The company's ability to use the net proceeds of the offering in a manner that will increase the value of shareholders' investment.
  • The company's and its subsidiaries' ability to execute on strategies and achieve future financial performance, including business plans, expansion, acquisitions, revenues, products, pricing, operating expenses, market trends, liquidity, cash flows, capital expenditures, and growth initiatives.
  • The company's ability to maintain control over its subsidiaries.
  • Access to funds under the Standby Equity Purchase Agreement with YA II PN, Ltd. due to certain conditions, restrictions, and limitations.
  • Restrictions and limitations set forth in the company's debt instruments, which may impair financial and operating flexibility.
  • The company's and its subsidiaries' ability to generate liquidity and maintain sufficient capital to operate as anticipated and continue as going concerns.
  • Risk that technology solutions licensed, acquired, or developed internally may not function as anticipated or provide the expected benefits.
  • Developments and projections relating to the company's and its subsidiaries' competitors and industry.
  • The ability of the company and its subsidiaries to scale the operations of their respective businesses and establish substantial commercial sales of their products.
  • The ability of the company and its subsidiaries to compete against companies with greater capital, resources, or superior technology or products.
  • The company's and its subsidiaries' ability to meet applicable regulatory requirements for product use and general business operations.
  • The outcome of any legal proceedings against the company or its subsidiaries.
  • The company's ability to find future opportunities to license or acquire breakthrough technology solutions from third parties and to satisfy requirements or avoid disagreements with Technology Solutions Providers.
  • Risk that the launch of new companies distracts the company's management from its and its other subsidiaries' operations.
  • Risk that the company may be deemed an investment company under the Investment Company Act, imposing burdensome compliance requirements and restrictions.
  • The ability of the company and its subsidiaries to sufficiently protect their intellectual property rights and to avoid or resolve disputes relating to third-party intellectual property use.
  • Risk of a cyber-attack or a failure of the company's or its subsidiaries' information technology and data security infrastructure.
  • Geopolitical risk and changes in applicable laws or regulations.
  • Potential adverse effects of other economic, business, and/or competitive factors.
  • Operational risks related to the company and its subsidiaries that have limited or no operating history.
  • Limited liquidity and trading of the company's securities.

Future Outlook

Innventure expects to use the net proceeds from the offering to fully repay outstanding convertible debentures, enhance working capital, and support general corporate purposes. The company anticipates increased flexibility to convert approximately $8 million of intercompany debt into equity in its rapidly scaling subsidiary, Accelsius, which operates in the 2-phase, direct-to-chip cooling market and has an expected sales opportunity pipeline exceeding $1 billion. Management believes the offering strengthens the balance sheet, accelerates the long-term strategy, and positions the company for continued growth and durable shareholder value.

Management Comments

  • "This offering strengthens much more than our balance sheet, it further accelerates Innventure's long-term strategy." Bill Haskell, Chief Executive Officer.
  • "Our model is built to unlock value from breakthrough technologies, and this capital allows us to advance that mission with even greater conviction." Bill Haskell, Chief Executive Officer.
  • "We now have enhanced flexibility to increase our ownership in Accelsius, a business that is rapidly scaling in the 2-phase, direct-to-chip cooling market with an expected sales opportunity pipeline exceeding $1 billion and significant strategic engagement across the industry." Bill Haskell, Chief Executive Officer.
  • "We are well positioned for growth and remain focused on driving durable shareholder value as we move through the quarters and years ahead." Bill Haskell, Chief Executive Officer.

Industry Context

Innventure operates as an industrial growth conglomerate, specializing in commercializing breakthrough technology solutions to build high-valuation companies. This capital raise directly supports its core strategy by providing funds to strengthen its financial foundation and invest further in key growth areas. The focus on Accelsius, a subsidiary in the 2-phase, direct-to-chip cooling market, highlights Innventure's engagement in advanced technology sectors, which are critical for data centers and high-performance computing, aligning with broader industry trends towards more efficient cooling solutions.

Comparison to Industry Standards

  • Accelsius's recent $65 million Series B-1 Units sale at a post-money valuation of approximately $665 million indicates strong investor confidence and a significant valuation for a company in the direct-to-chip cooling market.
  • The reported expected sales opportunity pipeline for Accelsius exceeding $1 billion suggests a substantial market presence and growth trajectory within its specialized cooling technology niche.
  • Innventure's stated goal of building companies with "billion-dollar valuations" sets an ambitious benchmark, implying a focus on high-impact, scalable technology ventures, which is a common aspiration among industrial growth conglomerates and venture builders.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Lock-up AgreementsExecutive officers and directors entered into 30-day lock-up agreements restricting sales of common stock and common stock equivalents.January 12, 2026Aligns management and director interests with the offering's success and long-term company performance by preventing immediate sales of shares.
Issuance RestrictionsThe company agreed to certain restrictions on the issuance and sale of common stock or common stock equivalents for a 30-day period following the closing of the offering.January 14, 2026Provides stability to the market for the newly issued shares by limiting further dilution or supply for a short period.

Related Party Transactions

  • Preemptive rights held by WTI Fund X, Inc. and WTI Fund XI, Inc. pursuant to warrants dated October 22, 2024, and April 14, 2025.
  • Standby Equity Purchase Agreement, dated October 24, 2023, with YA II PN, Ltd. (Yorkville).
  • Securities Purchase Agreements, dated March 25, 2025, and September 15, 2025, with Yorkville.

Stakeholder Impact

  • Shareholders: Existing shareholders will experience dilution from the issuance of new shares, but the capital raise strengthens the balance sheet and supports growth initiatives, potentially increasing long-term value.
  • Creditors: The planned repayment of outstanding convertible debentures will reduce the company's debt obligations, improving its credit profile and reducing financial risk.
  • Employees/Management: Executive officers and directors are subject to 30-day lock-up agreements, aligning their interests with the offering's success and long-term company performance.
  • Accelsius: The potential for Innventure to increase its equity ownership in Accelsius through debt conversion strengthens strategic alignment and provides further support for Accelsius's growth.

Next Steps

  • Repay outstanding convertible debentures.
  • Utilize net proceeds for working capital and general corporate purposes.
  • Potentially exercise the right to receive equity in Accelsius for intercompany debt repayment.
  • Continue to execute on long-term strategy and drive shareholder value.
  • Maintain the listing of Common Stock on the Nasdaq Stock Market LLC.

Key Dates

DateDescription
October 24, 2023Date of Standby Equity Purchase Agreement with YA II PN, Ltd. (Yorkville).
October 22, 2024Date of warrants to purchase common stock with WTI Fund X, Inc. and WTI Fund XI, Inc.
April 14, 2025Date of warrants to purchase common stock with WTI Fund X, Inc. and WTI Fund XI, Inc.
March 25, 2025Date of Securities Purchase Agreement with Yorkville.
September 15, 2025Date of Securities Purchase Agreement with Yorkville.
December 23, 2025Registration statement on Form S-3 (File No. 333-292427) filed with the SEC.
January 9, 2026Registration statement on Form S-3 declared effective by the SEC.
January 12, 2026Company entered into Securities Purchase Agreement and Placement Agency Agreement; issued press release announcing the pricing of the offering.
January 14, 2026Offering closed; company issued press release announcing the closing of the offering; prospectus supplement filed with the SEC.
January 16, 2026Latest engagement term for the Placement Agent, or the Closing Date under the Purchase Agreement.
February 1, 2026Automatic termination of Lock-Up Agreement if the Purchase Agreement has not been executed by this date.

Recommendation

hold

The successful capital raise strengthens Innventure's financial position by allowing debt repayment and providing funds for working capital and strategic investments, particularly in its high-growth subsidiary Accelsius. While the offering introduces dilution, the strategic benefits and the positive outlook for Accelsius suggest a stable to potentially growing long-term value. However, without more detailed financial performance metrics or a clear valuation impact, a 'hold' recommendation is prudent, acknowledging the positive strategic moves while awaiting further operational results.

Keywords

Innventure, INV, Public Offering, Common Stock, Equity Raise, Capital Raise, Convertible Debentures, Debt Repayment, Working Capital, Accelsius, Industrial Growth, Technology Commercialization, Placement Agent, Nasdaq, SEC Filing, Form 8-K, Institutional Investors, Lock-up Agreement, Direct-to-chip cooling

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.